跳至主要内容
临床试验/NCT06240364
NCT06240364撤回不适用

Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

University of Alicante2 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2025年10月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
入组人数
204
试验地点
2
主要终点
Changes from baseline osmolarity at 28, 56 and 84 days

研究概览

简要总结

Previous research has demonstrated the effectiveness of AFFRONEYE® / CROCUVIS+® dietary supplement, based on saffron extract, in the proper functioning of visual health, for example, against the development of glaucoma. The main objective of this study is to compare the results of clinical tests that evaluate signs and symptoms for the diagnosis of dry eye, between two groups (some that take the dietary supplement and others a placebo), in a sample of university workers and students who suffer from dry eye.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have dry eye according to the diagnostic criteria established by the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS).

排除标准

  • Pathology of the anterior ocular surface under treatment (such as conjunctivitis, keratitis, among others).
  • Take any type of dietary supplements, with or without botanical components in the last month.
  • Pregnancy or breastfeeding (also excludes recent pregnancy within the last 3 months) and women planning to become pregnant.

研究组 & 干预措施

Saffron extract (Crocus sativus)

Experimental

Daily intake of one tablet for 84 days.

干预措施: Saffron extract (Crocus sativus) (Dietary Supplement)

Placebo

Placebo Comparator

Daily intake of one tablet for 84 days. This tablet is organoleptically indistinguishable from the experimental tablet.

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Changes from baseline osmolarity at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Measured with the Tearlab osmometer. A positive result is considered to be ≥308 mOsm/L in either eye or an interocular difference \>8 mOsm/L.

Changes with respect to baseline NIBUT at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Non-Invasive tear BreakUp Time (NIBUT). It is measured with the Keratograph 5M topographer. It is used to assess tear film stability. It is a non-invasive method to observe and detect the tear film break-up time (measured in seconds). In this case, fluorescein staining can be dispensed with, thus eliminating any influence it may have on the tear film and the results. The region and time course of tear film rupture are automatically measured without user intervention. The software analyses the Placido projecting rings on the tear film and automatically detects any distortion or discontinuity in the reflected annular pattern. The results are recorded with respect to time and space, and translated into a colour-coded map. A positive finding has been reported to be a value \<10 s.

Changes with respect to baseline lipid layer of the tear film at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

The thickness of the lipid layer is not uniform throughout its structure and is examined by observing an interferential phenomenon with Keratograph 5M topographer. The ideal pattern is yellow to blue color at around 80-100nm. If excessively colored patterns are observed, this refers to a greater lipid film thickness \>100nm. If, on the other hand, the pattern is gray-white, it indicates a thin or absent lipid layer, causing greater evaporation.

Changes with respect to baseline MGD at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Meibomian Gland Dysfunction (MGD). The morphological changes of these glands are evaluated using the Keratograph 5M topographer using integrated infrared diodes that allow illumination of the everted eyelids. The Meibomian glands are located in the tarsal conjunctiva of the upper and lower eyelids and have the function of producing an oily substance (meibum), which forms the lipid layer of the tear film, protecting it against evaporation of its aqueous phase. The number of meibomian glands should be evaluated in the photographs taken; the larger the area without glands, the greater the DGM.

Changes from baseline dry eye symptoms at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Measured with Ocular Surface Disease Index (OSDI, adapted version to spanish). It consists of 12 items that assess symptoms, functional limitations, and environmental factors related to dry eye. The score ranges from 0 to 100 (worst). Each item is evaluated on a 4-point Likert scale (from 0 to 4). The final score is obtained from (the sum of scores for all questions answered x 25) and divide to total number of questions answered (do not included questions answered N/A); dry eye symptoms are considered from ≥ 13 points.

Changes with respect to baseline TMH at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Tear Meniscus Height (TMH). It is measured with the Keratograph 5M topographer. It assesses the height of the lacrimal meniscus (measured in millimetres). Firstly, it provides information on the secretory capacity of the main lacrimal gland and secondly, it may indicate a high evaporation rate, which may, for example, be due to an insufficient lipid layer. It is measured with a ruler from the point of the lower lid margin (below the centre of the pupil) to the upper edge of the lacrimal meniscus. A positive finding has been reported to be a value \<0.2 mm.

Changes with respect to baseline ocular surface stainings at 28, 56 and 84 days

时间窗: 0 (baseline), 28, 56 and 84 days

Ocular surface stains are used to assess epithelial damage to the cornea, conjunctiva, and lid margin. To assess corneal epithelial damage, a fluorescein strip is wet with saline, and a drop is instilled inside the lower temporal lid. Optimal viewing is 1-3 minutes after instillation. A positive result is \>5 corneal spots. To assess conjunctival and lid margin damage, a lissamine green strip is wet with saline, and a drop is instilled inside the lower temporal lid. The observation should occur between 1 and 4 min postinstillation. To assess conjunctival damage, a positive score is \> 9 conjunctival spots. To assess lid margin damage, ≥2 mm in length and/or ≥25% sagittal width is a positive score.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria del Mar Seguí Crespo

Senior Lecturer, PhD

University of Alicante

研究点 (2)

Loading locations...

相似试验